Dermalogica Clearing Defense SPF30

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

homosalate, Quantity: 80 mg/g; octocrylene, Quantity: 80 mg/g; octyl salicylate, Quantity: 50 mg/g; butyl methoxydibenzoylmethane, Quantity: 30 mg/g

Available from:

Dermalogica Pty Ltd

Pharmaceutical form:

Lotion

Composition:

Excipient Ingredients: purified water; acrylates/C10-30 alkyl acrylate crosspolymer; pentylene glycol; potassium cetyl phosphate; trisodium ethylenediamine disuccinate; 1,3-butylene glycol; xanthan gum; PEG-100 stearate; PVP/eicosene copolymer; arachidyl alcohol; arachidyl glucoside; behenyl alcohol; butyloctyl salicylate; dl-alpha-tocopheryl acetate; alkyl (C12-15) benzoate; propanediol; caprylyl glycol; saccharide isomerate; citric acid; sodium citrate; bisabolol; Camellia sinensis; ethylhexylglycerin; sodium hydroxide; tapioca starch; glyceryl monostearate; dipotassium glycyrrhizate; sodium ascorbyl phosphate; Coriandrum sativum; thymol; terpineol; Citrus aurantium; polyglyceryl-2 distearate; potassium sorbate; sodium benzoate; Salix alba; silicon dioxide

Administration route:

Topical

Therapeutic indications:

May assist in preventing some skin cancers (sunscreen) ; May reduce the risk of some skin cancers (sunscreen) ; SPF 30 Broad spectrum high protection sunscreen ; Can aid in the prevention of premature skin ageing (sunscreen) ; Can aid in the prevention of solar keratosis (sunscreen) ; Can aid in the prevention of sunspots (sunscreen)

Product summary:

Visual Identification: ;

Authorization status:

Listed

Authorization date:

2021-01-04